Volume 50, Issue 9 pp. 1032-1046
Original Article

Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan

Takashi Shida

Takashi Shida

Tsukuba Preventive Medicine, Research Center, Tsukuba University Hospital, Tsukuba, Japan

These authors contributed equally to this study.

Search for more papers by this author
Natsumi Oshida

Natsumi Oshida

Division of Laboratory Medicine, Tsukuba University Hospital, Tsukuba, Japan

These authors contributed equally to this study.

Search for more papers by this author
Hideo Suzuki

Hideo Suzuki

Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Search for more papers by this author
Kosuke Okada

Kosuke Okada

Tsukuba Preventive Medicine, Research Center, Tsukuba University Hospital, Tsukuba, Japan

Search for more papers by this author
Takahisa Watahiki

Takahisa Watahiki

Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

Search for more papers by this author
Sechang Oh

Sechang Oh

The Center for Sports Medicine and Health Sciences, Tsukuba University Hospital, Tsukuba, Japan

Search for more papers by this author
Taeho Kim

Taeho Kim

The Center for Sports Medicine and Health Sciences, Tsukuba University Hospital, Tsukuba, Japan

Search for more papers by this author
Tomonori Isobe

Tomonori Isobe

Medical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Search for more papers by this author
Yoshikazu Okamoto

Yoshikazu Okamoto

Division of Radiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Search for more papers by this author
Shun-ichi Ariizumi

Shun-ichi Ariizumi

Institute of Gastroenterology Surgery, Tokyo Women's Medical University, Tokyo, Japan

Search for more papers by this author
Masakazu Yamamoto

Masakazu Yamamoto

Institute of Gastroenterology Surgery, Tokyo Women's Medical University, Tokyo, Japan

Search for more papers by this author
Junichi Shoda

Corresponding Author

Junichi Shoda

Medical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Correspondence: Professor Junichi Shoda, Division of Medical Sciences, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan. Email: [email protected]Search for more papers by this author
First published: 29 June 2020
Citations: 35

Conflict of interest: The authors have no conflict of interest.

Abstract

Aim

The underlying mechanism of non-obese non-alcoholic fatty liver disease (NAFLD) has not been fully elucidated. We classified patients with NAFLD by sex and body mass index and compared their clinical features to clarify the background pathophysiology of non-obese NAFLD.

Methods

A total of 404 patients with NAFLD were divided according to their body mass index (<25 [non-obese], 25 to <30 [obese], and ≥30 [severe obese]), and were further compared with 253 patients without obesity and NAFLD (non-NAFLD).

Results

The proportion of the individuals with non-obese NAFLD was 25.7% in men and 27.6% in women. The male and female non-obese NAFLD groups had lower skeletal muscle mass and muscle strength than the obese NAFLD groups. The visceral fat area, although low, was ≥100 cm2 in 59.3% of men and 43.8% of women. An increase in liver fat accumulation, hepatic fibrosis, homeostasis model assessment of insulin resistance, and leptin levels was modest in the non-obese NAFLD group compared with a marked increase in the obese NAFLD groups. The muscle mass of the non-obese NAFLD group was similar to that of the non-NAFLD group, but muscle steatosis was particularly common among women. Multivariate analysis revealed that the factors contributing to increased liver fat accumulation in the non-obese NAFLD group were visceral fat area, HbA1c, myostatin, and leptin.

Conclusions

In patients with non-obese NAFLD, a sex difference was observed in the clinical features. In addition to increased visceral fat, decreased muscle mass and muscle strength, muscle atrophy (presarcopenia), and impaired glucose tolerance were considered to be important pathophysiological factors.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.